| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/25/2023 | 2.41% | Piper Sandler | $143 → $163 | Maintains | Neutral |
| 07/25/2023 | 3.67% | Morgan Stanley | $165 → $165 | Reiterates | Equal-Weight → Equal-Weight |
| 07/25/2023 | 8.7% | RBC Capital | $146 → $173 | Maintains | Sector Perform |
| 07/25/2023 | 1.78% | Barclays | $140 → $162 | Maintains | Equal-Weight |
| 07/25/2023 | 13.09% | Needham | $175 → $180 | Maintains | Buy |
| 07/25/2023 | 21.26% | Keybanc | $179 → $193 | Maintains | Overweight |
| 04/20/2023 | 3.67% | Morgan Stanley | $175 → $165 | Maintains | Equal-Weight |
| 04/20/2023 | 9.95% | Needham | → $175 | Reiterates | → Buy |
| 04/20/2023 | 6.81% | TD Cowen | $177 → $170 | Maintains | Outperform |
| 04/20/2023 | -8.27% | RBC Capital | $155 → $146 | Maintains | Sector Perform |
| 04/20/2023 | -2.61% | Credit Suisse | $166 → $155 | Maintains | Neutral |
| 04/20/2023 | -10.15% | Piper Sandler | $156 → $143 | Maintains | Neutral |
| 04/20/2023 | -12.04% | Barclays | $166 → $140 | Downgrades | Overweight → Equal-Weight |
| 04/20/2023 | 12.47% | Keybanc | $182 → $179 | Maintains | Overweight |
| 03/07/2023 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
| 01/25/2023 | 11.21% | Cowen & Co. | $187 → $177 | Maintains | Outperform |
| 01/25/2023 | 9.95% | Morgan Stanley | $190 → $175 | Maintains | Equal-Weight |
| 01/25/2023 | 4.3% | Credit Suisse | $173 → $166 | Maintains | Neutral |
| 01/25/2023 | 4.3% | Barclays | $180 → $166 | Maintains | Overweight |
| 01/25/2023 | 9.95% | Needham | $200 → $175 | Maintains | Buy |
| 01/25/2023 | 14.35% | Keybanc | $190 → $182 | Maintains | Overweight |
| 01/24/2023 | — | Guggenheim | Initiates Coverage On | → Neutral | |
| 01/18/2023 | 6.18% | Loop Capital | $211 → $169 | Maintains | Buy |
| 01/17/2023 | -0.1% | Piper Sandler | $164 → $159 | Maintains | Neutral |
| 12/20/2022 | 6.81% | JP Morgan | $190 → $170 | Maintains | Neutral |
| 12/13/2022 | 19.38% | Morgan Stanley | $170 → $190 | Maintains | Equal-Weight |
| 10/26/2022 | 3.04% | Piper Sandler | $173 → $164 | Maintains | Neutral |
| 10/26/2022 | 13.09% | Barclays | $205 → $180 | Maintains | Overweight |
| 10/26/2022 | 0.53% | RBC Capital | $175 → $160 | Maintains | Sector Perform |
| 10/26/2022 | 8.7% | Credit Suisse | $169 → $173 | Maintains | Neutral |
| 10/26/2022 | 25.66% | Needham | $303 → $200 | Maintains | Buy |
| 10/11/2022 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 10/11/2022 | 6.81% | Morgan Stanley | $205 → $170 | Maintains | Equal-Weight |
| 07/26/2022 | 7.44% | Credit Suisse | $167 → $171 | Maintains | Neutral |
| 07/26/2022 | 9.95% | RBC Capital | $200 → $175 | Maintains | Sector Perform |
| 07/26/2022 | 30.69% | Cowen & Co. | $212 → $208 | Maintains | Outperform |
| 07/26/2022 | 28.8% | Barclays | $216 → $205 | Maintains | Overweight |
| 07/20/2022 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 07/14/2022 | 6.81% | Citigroup | $210 → $170 | Maintains | Neutral |
| 07/14/2022 | 11.84% | JP Morgan | → $178 | Downgrades | Overweight → Neutral |
| 07/14/2022 | 4.93% | Credit Suisse | $225 → $167 | Downgrades | Outperform → Neutral |
| 07/13/2022 | 28.8% | Morgan Stanley | $235 → $205 | Maintains | Equal-Weight |
| 07/13/2022 | 8.7% | Piper Sandler | $197 → $173 | Downgrades | Overweight → Neutral |
| 04/27/2022 | 50.79% | B of A Securities | $265 → $240 | Maintains | Buy |
| 04/27/2022 | 47.65% | Morgan Stanley | $250 → $235 | Maintains | Equal-Weight |
| 04/27/2022 | 41.37% | Credit Suisse | $270 → $225 | Maintains | Outperform |
| 04/27/2022 | 23.77% | Piper Sandler | $227 → $197 | Maintains | Overweight |
| 04/27/2022 | 25.66% | RBC Capital | $210 → $200 | Maintains | Sector Perform |
| 04/12/2022 | 57.07% | Morgan Stanley | → $250 | Downgrades | Overweight → Equal-Weight |
| 02/14/2022 | 71.53% | Loop Capital | → $273 | Initiates Coverage On | → Buy |
| 01/26/2022 | 31.94% | Citigroup | $215 → $210 | Maintains | Neutral |
| 01/26/2022 | 69.64% | Credit Suisse | $278 → $270 | Maintains | Outperform |
| 01/26/2022 | 45.77% | Barclays | $234 → $232 | Maintains | Overweight |
| 01/26/2022 | 31.94% | RBC Capital | $220 → $210 | Maintains | Sector Perform |
| 01/20/2022 | 72.78% | JP Morgan | $245 → $275 | Maintains | Overweight |
| 01/19/2022 | 92.89% | Keybanc | → $307 | Initiates Coverage On | → Overweight |
| 01/10/2022 | 72.78% | Evercore ISI Group | $240 → $275 | Upgrades | In-Line → Outperform |
| 12/28/2021 | 90.37% | Needham | $265 → $303 | Maintains | Buy |
| 12/15/2021 | 75.92% | Morgan Stanley | $220 → $280 | Maintains | Overweight |
| 10/27/2021 | 74.67% | Credit Suisse | $238 → $278 | Maintains | Outperform |
| 07/27/2021 | 79.07% | B of A Securities | $210 → $285 | Upgrades | Neutral → Buy |
| 07/27/2021 | 66.5% | Needham | $255 → $265 | Maintains | Buy |
| 07/27/2021 | 49.54% | Credit Suisse | $235 → $238 | Maintains | Outperform |
| 07/27/2021 | 35.08% | RBC Capital | $200 → $215 | Maintains | Sector Perform |
| 07/27/2021 | 47.02% | Barclays | $233 → $234 | Maintains | Overweight |
| 06/10/2021 | 47.65% | Credit Suisse | → $235 | Upgrades | Neutral → Outperform |
| 06/01/2021 | 3.67% | Goldman Sachs | $191 → $165 | Downgrades | Neutral → Sell |
| 04/28/2021 | 27.54% | Credit Suisse | $207 → $203 | Maintains | Neutral |
| 04/28/2021 | 60.22% | Needham | $245 → $255 | Maintains | Buy |
| 04/08/2021 | 30.06% | Credit Suisse | → $207 | Downgrades | Outperform → Neutral |
| 01/27/2021 | 38.23% | Morgan Stanley | $205 → $220 | Maintains | Overweight |
| 01/27/2021 | 53.93% | Needham | $235 → $245 | Maintains | Buy |
| 01/14/2021 | 47.65% | Barclays | $212 → $235 | Maintains | Overweight |
| 01/08/2021 | 30.06% | Credit Suisse | $205 → $207 | Maintains | Outperform |
| 01/08/2021 | 47.65% | Needham | $210 → $235 | Maintains | Buy |
| 12/15/2020 | 28.8% | Morgan Stanley | $175 → $205 | Maintains | Overweight |
| 11/25/2020 | 13.09% | B of A Securities | $124 → $180 | Upgrades | Underperform → Neutral |
| 11/19/2020 | 28.8% | Credit Suisse | $185 → $205 | Maintains | Outperform |
| 11/19/2020 | 31.94% | Needham | $180 → $210 | Maintains | Buy |
| 11/16/2020 | 20.63% | JP Morgan | → $192 | Upgrades | Neutral → Overweight |
| 10/27/2020 | 16.24% | Credit Suisse | $184 → $185 | Maintains | Outperform |
| 10/22/2020 | 15.61% | Credit Suisse | $183 → $184 | Maintains | Outperform |
| 07/28/2020 | 14.98% | Credit Suisse | $170 → $183 | Maintains | Outperform |
| 07/28/2020 | 13.09% | Needham | $170 → $180 | Maintains | Buy |
| 07/24/2020 | 19.38% | Wolfe Research | → $190 | Initiates Coverage On | → Outperform |
| 07/20/2020 | 6.81% | Credit Suisse | $151 → $170 | Maintains | Outperform |
| 07/09/2020 | 9.95% | Morgan Stanley | → $175 | Upgrades | Equal-Weight → Overweight |
| 04/29/2020 | -12.04% | Citigroup | $112 → $140 | Maintains | Neutral |
| 04/28/2020 | -8.9% | JP Morgan | $138 → $145 | Maintains | Neutral |
| 04/28/2020 | -5.13% | Credit Suisse | $156 → $151 | Maintains | Outperform |
| 04/28/2020 | -15.18% | Morgan Stanley | $115 → $135 | Maintains | Equal-Weight |
| 04/28/2020 | 3.67% | Nomura | $145 → $165 | Maintains | Buy |
| 04/28/2020 | 3.67% | Nomura | $145 → $165 | Maintains | Buy |
| 04/28/2020 | 6.81% | Needham | $151 → $170 | Maintains | Buy |
| 04/09/2020 | -1.99% | Credit Suisse | $160 → $156 | Maintains | Outperform |
| 04/06/2020 | -12.04% | Needham | $160 → $140 | Maintains | Buy |
| 03/23/2020 | -8.9% | Nomura | $175 → $145 | Maintains | Buy |
| 03/19/2020 | -27.75% | Morgan Stanley | $135 → $115 | Maintains | Equal-Weight |
| 03/04/2020 | -21.46% | Citigroup | $165 → $125 | Maintains | Neutral |
| 02/10/2020 | 0.53% | Needham | → $160 | Upgrades | Hold → Buy |
| 01/28/2020 | 0.53% | Credit Suisse | $163 → $160 | Maintains | Outperform |
| 01/28/2020 | -7.64% | RBC Capital | $157 → $147 | Maintains | Sector Perform |
| 01/28/2020 | -14.55% | B of A Securities | $140 → $136 | Reiterates | → Underperform |
| 01/28/2020 | 9.95% | Nomura | $180 → $175 | Maintains | Buy |
| 12/20/2019 | 6.18% | Cowen & Co. | $185 → $169 | Maintains | Outperform |
| 12/20/2019 | 2.41% | Credit Suisse | $192 → $163 | Maintains | Outperform |
| 12/05/2019 | -12.04% | B of A Securities | $185 → $140 | Downgrades | Buy → Underperform |
| 12/04/2019 | -12.04% | B of A Securities | $185 → $140 | Downgrades | Buy → Underperform |
| 10/25/2019 | 4.3% | MKM Partners | $164 → $166 | Maintains | Neutral |
| 10/24/2019 | 6.81% | Barclays | $160 → $170 | Maintains | Overweight |
| 09/11/2019 | -12.04% | Evercore ISI Group | → $140 | Initiates Coverage On | → In-Line |
| 09/09/2019 | 4.3% | Piper Sandler | $161 → $166 | Upgrades | Neutral → Overweight |
| 08/08/2019 | -18.32% | Morgan Stanley | → $130 | Upgrades | Underweight → Equal-Weight |
| 08/08/2019 | 0.53% | Barclays | → $160 | Initiates Coverage On | → Overweight |
| 07/25/2019 | 20.01% | Credit Suisse | $188 → $191 | Maintains | Outperform |
| 07/18/2019 | 18.12% | Credit Suisse | $211 → $188 | Maintains | Outperform |
| 07/08/2019 | -24.6% | Goldman Sachs | $165 → $120 | Downgrades | Neutral → Sell |
| 04/01/2019 | 13.09% | Nomura | $155 → $180 | Upgrades | Neutral → Buy |
| 03/29/2019 | 2.41% | Piper Sandler | $157 → $163 | Upgrades | Underweight → Neutral |
| 03/12/2019 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 01/17/2019 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 10/25/2018 | 36.97% | Credit Suisse | $216 → $218 | Maintains | Outperform |
| 10/25/2018 | 22.52% | BMO Capital | $188 → $195 | Maintains | Outperform |
| 10/12/2018 | — | Standpoint Research | Upgrades | Hold → Buy | |
| 10/01/2018 | 13.09% | Piper Sandler | $168 → $180 | Downgrades | Neutral → Underweight |
| 09/05/2018 | 35.71% | Credit Suisse | $188 → $216 | Maintains | Outperform |
What is the target price for F5 (FFIV)?
The latest price target for F5 (NASDAQ: FFIV) was reported by Piper Sandler on July 25, 2023. The analyst firm set a price target for $163.00 expecting FFIV to rise to within 12 months (a possible 2.41% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for F5 (FFIV)?
The latest analyst rating for F5 (NASDAQ: FFIV) was provided by Piper Sandler, and F5 maintained their neutral rating.
When is the next analyst rating going to be posted or updated for F5 (FFIV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of F5, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for F5 was filed on July 25, 2023 so you should expect the next rating to be made available sometime around July 25, 2024.
Is the Analyst Rating F5 (FFIV) correct?
While ratings are subjective and will change, the latest F5 (FFIV) rating was a maintained with a price target of $143.00 to $163.00. The current price F5 (FFIV) is trading at is $159.16, which is within the analyst's predicted range.